Bacteriostatic water for injection
Bacteriostatic Water for Injection, USP is a real, FDA-regulated pharmaceutical product — not a generic diluent — and most of what people get wrong about it comes down to treating two separate questions as one: whether it is the right liquid to use, and how long whatever you dissolve in it stays good afterward. This page answers both, sourced directly from the product's own FDA labeling and CDC's multi-dose-vial guidance.
What's actually in the vial
Strip away the name and the product is simple: Water for Injection, USP — chemically just H₂O, manufactured and tested to a sterile, nonpyrogenic pharmaceutical standard — with a small amount of benzyl alcohol added as a preservative. That preservative is the entire reason the product exists as a separate SKU from plain sterile water, and its concentration is not a single fixed number the way most casual descriptions imply. Hospira's own FDA-approved labeling lists two different concentrations depending on the vial:
| Package | Benzyl alcohol |
|---|---|
| 30 mL multi-dose plastic vial | 0.9% (9 mg/mL) |
| 20 mL fill in a 30 mL glass vial | 1.1% (11 mg/mL) |
0.9% is the figure most people mean when they say “bacteriostatic water,” and it's the plastic-vial number — but the concentration is printed on your own vial's label, and that is the number that actually applies to what you're holding, not a number quoted from a webpage. The solution's pH runs 4.5 to 7.0 (typically 5.7), and it is sold Rx only — a prescription pharmaceutical, the same regulatory category as most of what gets mixed into it.
Source: Hospira Bacteriostatic Water for Injection, USP, full prescribing information, Description and How Supplied sections, revised 08/2019, fetched from DailyMed August 2026. View the label on DailyMed.
Why the benzyl alcohol is the whole point
The label describes the product as supplied in a “multiple-dose container from which repeated withdrawals may be made”, and the benzyl alcohol is what makes that safe: it suppresses bacterial growth across each new puncture of the stopper, which is the exact hazard a preservative-free vial cannot manage after its first entry. That is the entire practical distinction between this product and Sterile Water for Injection — the unpreserved version, labeled for single use only, because nothing in it stops whatever gets introduced through the needle from multiplying. It is also, on its own, not a fluid a person should ever inject without something dissolved in it: the same label warns that intravenous administration of bacteriostatic water without a solute can cause hemolysis (red blood cell breakdown) — a reminder that this is a diluent for another drug, not a product with a use of its own.
When sterile water is the correct choice instead: neonates
Bacteriostatic Water for Injection carries a boxed warning printed directly on its label: “NOT FOR USE IN NEONATES.” This is not a general caution rounded up for safety's sake — it is a specific contraindication tied to a known toxicity, and the label states the substitute plainly: where water is needed to prepare or dilute a medication for a neonate, only preservative-free Sterile Water for Injection should be used, because data on the safety of other preservatives in that age group simply does not exist.
The history behind that warning is a specific, published clinical finding, not a theoretical worry. In the early 1980s, physicians at a New Orleans neonatal intensive care unit traced a cluster of deaths and a distinctive collapse — gasping respirations, metabolic acidosis, progressive neurologic deterioration — to benzyl-alcohol-preserved flush solutions used routinely on low-birth-weight infants. Once the preservative was removed from the unit's flush and IV fluids, the syndrome stopped appearing. That report is why every benzyl-alcohol-preserved product sold in the U.S. today carries a neonatal warning, this one included. It says nothing about adult use — the toxicity is dose- and body-weight-dependent, and an adult metabolizes benzyl alcohol in a way a premature infant cannot — but it is the reason this specific diluent is not a universal, risk-free default for every population.
Sources: Hospira Bacteriostatic Water for Injection, USP labeling, Warnings and Contraindications sections, fetched August 2026 (view on DailyMed); Gershanik J, Boecler B, Ensley H, et al., “The Gasping Syndrome and Benzyl Alcohol Poisoning,” New England Journal of Medicine, 1982 (PMID 7133084 on PubMed), re-verified live August 2026.
Two different clocks — the 28-day rule is not the peptide's shelf life
This is the single most common mixing-related mistake in how people talk about handling peptides, and it comes from treating one number as if it answers two different questions. The number in circulation is 28 days, and it is real — but it describes only one of the two clocks that start running the moment a vial is punctured.
Clock 1 — the diluent's antimicrobial dating
Bacteriostatic water's own label states an unopened vial's storage condition (room temperature, 20–25°C) but prints no discard date for after the stopper has been punctured. That gap is filled by USP General Chapter <797>, which CDC's own injection-safety guidance for providers states directly: “Once a multi-dose vial is opened (e.g., needle-punctured) the vial should be dated and discarded within 28 days unless the manufacturer states another date for that opened vial.” That 28-day figure is a ceiling on how long the water's own preservative system can be trusted to keep repeated punctures sterile — nothing more.
Clock 2 — the dissolved peptide's own stability
How long the specific compound you dissolved stays chemically and physically intact is a completely separate question, governed by that molecule's own formulation stability — not by the water. A concrete, labeled example: EGRIFTA SV (tesamorelin), an FDA-approved peptide product reconstituted with sterile water because it's a single-dose vial, carries an instruction with no ambiguity at all — “administer immediately following reconstitution… do not freeze or refrigerate the reconstituted solution.” That is a real peptide's own manufacturer-established stability window: effectively zero days, dramatically shorter than the water's own 28-day vial-entry ceiling.
Neither clock overrides the other — a vial past its 28-day mark should be discarded regardless of what's dissolved in it, and a reconstituted product past its own formulation's stability window should be discarded even if the water is still well inside its 28 days. Treat 28 days as the outer boundary the diluent itself imposes, never a guarantee about what you mixed into it, and never a number that overrides whatever storage instruction came with the specific product — a compounding pharmacy or a manufacturer that states a shorter window has the more specific, and more authoritative, answer.
Sources: CDC, “Preventing Unsafe Injection Practices,” Injection Safety provider guidance, citing USP General Chapter <797>, fetched August 2026 (cdc.gov); EGRIFTA SV (tesamorelin) full prescribing information, Dosage and Administration section 2.2, fetched August 2026 (view on DailyMed).
Where to go next
- Ready to actually mix a vial? Our reconstitution walkthrough covers the mechanical steps, then hands off to the calculator for the exact volume.
- Have a vial size and a prescribed dose in hand? Our reconstitution calculator does that arithmetic for 16 molecules.
- Mixed and ready to draw up a dose? Our injection technique and site-rotation guide covers what comes after mixing.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
This page describes an FDA-regulated pharmaceutical product and general handling guidance. It is not a recommendation to use any specific peptide, and it is not a substitute for instructions from the pharmacy or clinician that dispensed your prescription. Read our full medical disclaimer.
Every source on this page was fetched live on August 2026.